Organ disfunction after the preparative regimen predicts for severe graft vs. host disease (GVHD) in patients undergoing allogeneic blood stem cell transplantation.

被引：0
|
作者：
Haire, WD
Lynch, JC
Pavletic, SZ
Schneider, J
Tarantolo, S
机构：
[1] Univ Nebraska, Med Ctr, Hematol Oncol Sect, Omaha, NE USA
[2] Univ Nebraska, Med Ctr, Dept Societal & Prevent Med, Omaha, NE USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
686
引用
收藏
页码：157A / 157A
页数：1
相关论文
共 50 条
  • [1] Tacrolimus vs cyclosporine for prevention of acute graft-vs-host disease (GVHD) after allogeneic blood stem cell transplantation.
    Przepiorka, D
    Ippoliti, C
    Khouri, I
    Anderlini, P
    Stein, L
    vanBesien, K
    Mehra, R
    Giralt, S
    Gajewski, J
    Fritsche, H
    Deisseroth, AB
    Cleary, K
    Champlin, R
    Andersson, B
    Korbling, M
    BLOOD, 1995, 86 (10) : 1568 - 1568
  • [2] Chronic graft-vs-host disease (GVHD) after allogeneic marrow or blood stem cell transplantation
    Anderlini, P
    Przepiorka, D
    Khouri, I
    vanBesien, K
    Mehra, R
    Giralt, S
    Gajewski, J
    Cleary, K
    Champlin, R
    Andersson, B
    Korbling, M
    BLOOD, 1995, 86 (10) : 421 - 421
  • [3] Chemokine profiling in patients with graft versus host disease (GVHD) following allogeneic blood stem cell transplantation.
    Ziegler, Judy A.
    Lokshin, Anna
    Lentzsch, Suzanne
    Agha, Mounzer
    Arnold, Renate
    Mapara, Markus Y.
    BLOOD, 2006, 108 (11) : 814A - 815A
  • [4] Allogeneic blood stem cell transplantation: Graft vs host disease (GVHD) and graft vs leukemia (GVL) effect
    Korbling, M
    BONE MARROW TRANSPLANTATION, 1998, 22 : S6 - S6
  • [5] Microdose methotrexate vs methylprednisolone in combination with tacrolimus for prevention of acute graft-vs-host disease (GVHD) after allogeneic blood stem cell transplantation.
    Przepiorka, D
    Ippoliti, C
    Khouri, I
    Anderlini, P
    LeBherz, D
    vanBesien, K
    Ueno, N
    Mehra, R
    Giralt, S
    Gajewski, J
    Fritsche, H
    Cleary, K
    Claxton, D
    Champlin, R
    Andersson, B
    Korbling, M
    BLOOD, 1996, 88 (10) : 1659 - 1659
  • [6] Graft vs. Host Disease incidence in patients with allogeneic peripheral blood progenitor cells transplantation.
    Milone, G
    Rolón, JM
    Fernandez, I
    Corrado, C
    Desmery, P
    Pavlovsky, S
    BLOOD, 1999, 94 (10) : 370B - 370B
  • [7] Impact of prophylaxis regimen on the incidence of acute graft-versus-host disease after allogeneic blood stem cell transplantation.
    Przepiorka, D
    Ippoliti, C
    Khouri, I
    Anderlini, P
    Folloder, J
    Ueno, N
    Mehra, R
    Giralt, S
    Gajewski, J
    Cleary, K
    Claxton, D
    Champlin, R
    Andersson, B
    Körbling, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S107 - S107
  • [8] Analysis of graft versus host disease and outcome in 100 patients undergoing allogeneic peripheral blood stem cell transplantation.
    Miflin, G
    Cook, G
    Franklin, I
    Morrison, A
    Green, R
    Hutchinson, RM
    Milligan, D
    Auer, R
    Potter, MN
    Morgan, GJ
    Pagliuca, A
    Marsh, J
    Bell, A
    Russell, NH
    BONE MARROW TRANSPLANTATION, 1998, 21 : S107 - S107
  • [9] Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation
    Wechalekar, A
    Cranfield, T
    Sinclair, D
    Ganzckowski, M
    CLINICAL AND LABORATORY HAEMATOLOGY, 2005, 27 (04): : 247 - 249
  • [10] Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors
    Nicolaus Kröger
    Tatjana Zabelina
    William Krüger
    Helmut Renges
    Norbert Stute
    Matthias Dürken
    Friedrich Graf von Finkenstein
    Rolf Erttmann
    Hartmut Kabisch
    Philipe Schafhausen
    Nicole Jaburg
    Cornelius Löliger
    Axel R Zander
    Annals of Hematology, 2001, 80 : 209 - 215
12345